MARDIROSSIAN, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 3.199
EU - Europa 2.362
AS - Asia 2.316
SA - Sud America 331
AF - Africa 94
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.319
Nazione #
US - Stati Uniti d'America 3.097
SG - Singapore 763
IT - Italia 677
CN - Cina 623
PL - Polonia 550
SE - Svezia 274
BR - Brasile 267
VN - Vietnam 227
HK - Hong Kong 223
FR - Francia 139
DE - Germania 133
KR - Corea 116
FI - Finlandia 91
GB - Regno Unito 88
IN - India 85
RU - Federazione Russa 81
NL - Olanda 66
CA - Canada 59
TR - Turchia 59
UA - Ucraina 54
JP - Giappone 48
IE - Irlanda 43
MA - Marocco 43
BG - Bulgaria 40
MX - Messico 29
BD - Bangladesh 22
CH - Svizzera 22
AR - Argentina 21
IQ - Iraq 18
PK - Pakistan 17
AT - Austria 16
BE - Belgio 16
CZ - Repubblica Ceca 16
HR - Croazia 16
ID - Indonesia 15
ZA - Sudafrica 15
ES - Italia 14
TW - Taiwan 14
SA - Arabia Saudita 13
AU - Australia 10
PH - Filippine 10
SN - Senegal 10
MY - Malesia 9
PE - Perù 9
TH - Thailandia 9
CO - Colombia 8
EC - Ecuador 8
KE - Kenya 8
UZ - Uzbekistan 7
EG - Egitto 6
DK - Danimarca 5
NP - Nepal 5
RO - Romania 5
BO - Bolivia 4
GR - Grecia 4
KZ - Kazakistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EU - Europa 3
IL - Israele 3
MN - Mongolia 3
PY - Paraguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CL - Cile 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
LK - Sri Lanka 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
UY - Uruguay 2
AL - Albania 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GH - Ghana 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 8.311
Città #
Singapore 496
Warsaw 496
Ashburn 412
Fairfield 250
San Jose 242
Trieste 238
Chandler 218
Hong Kong 213
Beijing 183
Woodbridge 153
Wilmington 115
Houston 106
Seoul 106
Ann Arbor 96
Hefei 90
Seattle 90
Ho Chi Minh City 75
Cambridge 65
Princeton 64
Boardman 63
Los Angeles 61
Columbus 60
Jacksonville 60
Chicago 56
Helsinki 55
Council Bluffs 51
Hanoi 50
Lauterbourg 46
Milan 45
New York 42
Dublin 41
Casablanca 40
Sofia 39
The Dalles 39
Redmond 37
Zgierz 35
Dallas 34
Frankfurt am Main 34
Santa Clara 32
London 31
Izmir 29
Moscow 29
Nuremberg 24
São Paulo 24
Tokyo 24
North Bergen 23
Orem 23
Buffalo 21
Dearborn 21
Munich 19
Rome 19
Nanjing 18
Ottawa 18
Bologna 16
Porto Alegre 16
Pune 16
Chennai 15
Lappeenranta 15
Da Nang 14
Dong Ket 14
Falls Church 14
Toronto 14
Brussels 13
Phoenix 13
Venice 13
Brooklyn 12
Des Moines 12
Paris 12
Vienna 12
Amsterdam 11
Atlanta 11
Guangzhou 11
Mexico City 11
Montreal 11
Washington 11
Bern 10
Dakar 10
Redondo Beach 10
Rio de Janeiro 10
San Diego 10
Shanghai 10
Taipei 10
Brno 9
Düsseldorf 9
Hangzhou 9
Miano 9
Norwalk 9
Baghdad 8
Bremen 8
Kunming 8
Changsha 7
Denver 7
Johannesburg 7
Nairobi 7
Tashkent 7
Wroclaw 7
Istanbul 6
Kahramanmaraş 6
Kochi 6
Lublin 6
Totale 5.443
Nome #
D-BMAP18 antimicrobial peptide is active In Vitro, resists to pulmonary proteases but loses its activity in a murine model of Pseudomonas aeruginosa lung infection 381
Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome 370
Myticalins: A novel multigenic family of linear, cationic antimicrobial peptides from marine mussels (Mytilus spp.) 365
Proline-rich antimicrobial peptides targeting protein synthesis 353
Sviluppo e caratterizzazione di scaffold a base di polisaccaridi con proprietà antimicrobiche per la rigenerazione tissutale 290
Antibacterial Electrospun Polycaprolactone Membranes Coated with Polysaccharides and Silver Nanoparticles for Guided Bone and Tissue Regeneration 275
The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome 271
Induced expression of cathelicidins in trout (Oncorhynchus mykiss) challenged with four different bacterial pathogens 247
Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria 238
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 235
Proteolytic Activity of Escherichia coli Oligopeptidase B Against Proline-Rich Antimicrobial Peptides. 230
Methods for elucidating the mechanism of action of proline-rich and other non-lytic antimicrobial peptides 223
Anisaxins, helical antimicrobial peptides from marine parasites, kill resistant bacteria by lipid extraction and membrane disruption 221
Antibacterial rifampicin-loaded electrospun polycaprolactone membranes for ureteral regeneration 218
Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1–25) That Retain Antimicrobial Activity by Blocking Protein Synthesis 212
L-PRF Enrichment with Nanohydroxiapatite: An In Vitro Proof of Concept Study 204
Peptide Inhibitors of Bacterial Protein Synthesis with Broad Spectrum and SbmA-Independent Bactericidal Activity against Clinical Pathogens 202
Antimicrobial activity of amphiphilic nanomicelles loaded with curcumin against Pseudomonas aeruginosa alone and activated by blue laser light 193
Inner membrane proteins YgdD and SbmA are required for the complete susceptibility of escherichia coli to the proline-rich antimicrobial peptide arasin 1(1–25) 180
Lipopolysaccharide phosphorylation by the WaaY kinase affects the susceptibility of Escherichia coli to the human antimicrobial peptide LL-37 174
Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis 174
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation 173
The anti-pseudomonal peptide d-bmap18 is active in cystic fibrosis sputum and displays anti-inflammatory in vitro activity 166
null 163
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia 162
Characterization of cetacean proline-rich antimicrobial peptides displaying activity against eskape pathogens 160
Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin 156
Rifampicin-loaded electrospun polycaprolactone membranes: Characterization of stability, antibacterial effects and urotheliocytes proliferation 155
Effects of lipidation on a proline-rich antibacterial peptide 155
Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections 152
Proline-Rich Peptides with Improved Antimicrobial Activity against E. coli, K. pneumoniae, and A. baumannii 142
Novel synthesis of 1,2-diaza-1,3-dienes with potential biological activity from cinnamic acids and diazonium salts of anilines 140
Advantages of agarose on alginate for the preparation of polysaccharide/hydroxyapatite porous bone scaffolds compatible with a proline-rich antimicrobial peptide 134
Core-shell electrospun polycaprolactone nanofibers, loaded with rifampicin and coated with silver nanoparticles, for tissue engineering applications 127
Polyetheretherketone and titanium surface treatments to modify roughness and wettability – Improvement of bioactivity and antibacterial properties 127
The proline-rich myticalins from Mytilus galloprovincialis display a membrane-permeabilizing antimicrobial mode of action 122
Paenilamicins are context-specific translocation inhibitors of protein synthesis 120
The proline-rich antimicrobial peptide B7-005: low bacterial resistance, safe for human cells and effective in zebrafish embryo bacteraemia model 117
The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis 116
Recent applications of retro-inverso peptides 109
Natural and synthetic halogenated amino acids—structural and bioactive features in antimicrobial peptides and peptidomimetics 107
Structural and biological characterization of shortened derivatives of the cathelicidin PMAP-36 105
Antimicrobial Peptide with a Bent Helix Motif Identified in Parasitic Flatworm Mesocestoides corti 103
Unveiling the Impact of Gene Presence/Absence Variation in Driving Inter-Individual Sequence Diversity within the CRP-I Gene Family in Mytilus spp 97
Identification of genes involved in the resistance to the human antimicrobial peptide LL-37 in E. coli 88
Potential novel therapeutic strategies in cystic fibrosis: Antimicrobial and anti-biofilm activity of natural and designed -helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia 61
Two Shorter Variants of the Proline-Rich Antimicrobial Peptide B7-005 Scaffold Active Against Clinical Isolates of Pseudomonas aeruginosa and Staphylococcus aureus 10
Comparative analysis of lignin peroxidase and laccase responses to graphene-related nanomaterials 6
The structure of the Vibrio natriegens 70S ribosome in complex with the proline-rich antimicrobial peptide Bac5(1–17) 5
Mechanistic Divergence and Differential Antibacterial Potency of the Proline-Rich Antimicrobial Peptide B7-005 Across ESKAPE + E Pathogens 5
Testing antimicrobial peptides inhibiting protein synthesis in living E. coli and K. pneumoniae using bio-orthogonal non-canonical amino-acid tagging 3
Fragments of cathelicidins PMAP-36 and BMAP-27 and their D-enantiomers: Effects of all D substitutions on structure, protease resistance and antimicrobial properties 3
Designing New Chimeric Proline-Rich Antimicrobial Peptides to Enhance Efficacy Toward the ESKAPE+E: Beyond Sequence Extension 3
Totale 8.548
Categoria #
all - tutte 23.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 0 27 50
2021/2022529 24 48 49 67 26 29 24 15 59 44 37 107
2022/2023797 73 107 51 131 67 115 20 72 63 21 41 36
2023/2024660 31 36 56 26 71 75 115 97 24 24 59 46
2024/20251.455 24 53 65 155 142 141 92 85 184 225 138 151
2025/20263.132 363 158 199 314 293 276 426 116 386 506 95 0
Totale 8.548